Author:
Kelaini Sophia,Cochrane Amy,Margariti Andriana
Publisher
Springer International Publishing
Reference86 articles.
1. Amabile G, Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med. 2009;15(2):59–68. PubMed Epub 2009/01/24. eng.
2. Garber K. Between disease and a dish. Nat Biotechnol. 2014;32(8):712–5.
3. Sinnecker D, Dirschinger RJ, Goedel A, Moretti A, Lipp P, Laugwitz KL. Induced pluripotent stem cells in cardiovascular research. Rev Physiol Biochem Pharmacol. 2012;163:1–26. PubMed Epub 2012/03/27. eng.
4. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007;318(5858):1920–3. PubMed Epub 2007/12/08. eng.
5. Rashid ST, Corbineau S, Hannan N, Marciniak SJ, Miranda E, Alexander G, et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest. 2010;120(9):3127–36. Pubmed Central PMCID: Pmc2929734. Epub 2010/08/27. eng.